Better Buy: Eli Lilly vs. Viking Therapeutics

Comparing Eli Lilly (LLY 3.77%) and Viking Therapeutics (VKTX 10.60%) might initially seem odd. The two drugmakers don't seem to have much in common. Eli Lilly is more than 50 times the size of Viking by market cap and boasts a long list of approved medicines and an impressive track record of success. Viking Therapeutics, on the other hand, is a clinical-stage, mid-cap biotech stock whose most advanced candidate isn't even in a late-stage study yet. Yet for invest purposes, is there any reason to choose Vik ...